WallStreetZenWallStreetZen

NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John VavrickaChief Commercial Officer2025-01-3111,517$3.06
$35.24kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2025-01-3116,102$3.06
$49.27kSell
Wayne FosterEVP Chief Accounting Officer2025-01-3112,062$3.06
$36.91kSell
Janet Mj HammondChief Development Officer2025-01-3114,134$3.06
$43.25kSell
Maria Arantxa HorgaChief Medical Officer2025-01-3116,071$3.06
$49.18kSell
Jeanpierre SommadossiPresident CEO and Chairman2025-01-3188,601$3.06
$271.12kSell
Franklin M. BergerDirector2025-01-1610,000$3.36
$33.61kBuy
Franklin M. BergerDirector2025-01-1610,000$3.36
$33.61kBuy
Franklin M. BergerDirector2025-01-1515,000$3.19
$47.88kBuy
Franklin M. BergerDirector2025-01-1515,000$3.19
$47.88kBuy

1 of 2

AVIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.13%8,668,527$31.73MInstitution
Bml Capital Management LLC8.89%7,609,812$27.85MInstitution
Cormorant Asset Management LP7.49%6,411,355$23.47MInsider
Jeanpierre Sommadossi7.21%6,166,965$22.57MInsider
Fmr LLC6.68%5,719,758$20.93MInstitution
Andrew A. F. Hack6.56%5,615,659$20.55MInsider
Tang Capital Management LLC5.71%4,889,200$17.89MInstitution
Vanguard Group Inc5.71%4,887,221$17.89MInstitution
Bain Capital Life Sciences Investors LLC2.90%2,485,638$9.10MInstitution
Geode Capital Management LLC2.25%1,925,573$7.05MInstitution

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR61.55%25.34%Net Selling
ALT37.20%62.80%Net SellingNet Buying
FHTX72.45%14.12%Net Selling
DMAC16.68%62.62%Net BuyingNet Buying
CAPR26.07%73.93%Net Buying
View Top Biotech Stocks

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 61.55% institutional shareholders, 25.34% Atea Pharmaceuticals insiders, and 13.11% retail investors. Cormorant Asset Management LP is the largest individual Atea Pharmaceuticals shareholder, owning 6.41M shares representing 7.49% of the company. Cormorant Asset Management LP's Atea Pharmaceuticals shares are currently valued at $23.47M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.